Motrin Ib Migraineibuprofen

According to the FDA label: Uses temporarily relieves minor aches and pains due to: headache toothache backache menstrual cramps the common cold muscular aches minor pain of arthritis temporarily reduces fever

195,320 adverse event reports submitted to the FDA (1998–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Motrin Ib Migraine in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Motrin Ib Migraine adverse event reports by reporter sex
SexReports
Female113,738
Male62,207
Unknown600

By Age Group

View age group data as a table
Motrin Ib Migraine adverse event reports by reporter age group
Age groupReports
0-1712,654
18-3421,743
35-4932,078
50-6437,243
65-7418,633
75+12,407

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Motrin Ib Migraine. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Motrin Ib Migraine adverse event reports by reported outcome
OutcomeReports
Other Serious93,403
Hospitalization69,250
Non-Serious53,030
Death15,946
Life-Threatening12,785
Disability8,957

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Motrin Ib Migraine. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Motrin Ib Migraine adverse event reports by year
YearReports
19981
20012
20021
20035
20041,608
20052,142
20062,049
20072,110
20081,778
20092,762
20103,971
20115,691
20127,047
20136,747
20146,564
20159,096
201612,495
201711,336
201815,595
201916,669
202015,471
202115,285
202214,857
202313,691
202412,627
202512,721
2026 (partial)2,999

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Motrin Ib Migraine

In FDA adverse event reports that mention Motrin Ib Migraine, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026